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Preferred RNA Binding Sites for a Threading
Intercalator Revealed by In Vitro Evolution
which numerous compounds, including ethidium, acri-
dine, and ellipticine, bind via intercalation [12]. These
compounds, however, do not bind the RNA with a high
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potential strategy for rendering an intercalator RNA se-
lective has been suggested [13]. Since the rates of base-
pair opening in structured RNA vary with proximity toSummary
duplex irregularities (e.g., internal loops) [14], one might
target these sites with a threading intercalator.In pursuit of small molecules capable of controlling
Threading intercalation involves insertion of an inter-the function of RNA targets, we have explored the RNA
calator between base pairs of a nucleic acid duplexbinding properties of peptide-acridine conjugates
and localization of distinguishable substituents on the(PACs). In vitro evolution (SELEX) was used to isolate
heterocycle in opposite grooves of the helix [15–17].RNAs capable of binding the PAC Ser-Val-Acr-Arg,
One of the side chains is required to pass through thewhere Acr is an acridine amino acid. The PAC binds
duplex (or thread) during the binding event, thus givingRNA aptamers selectively and with a high degree of
this binding mode its name. Since a transient openingdiscrimination over DNA. PAC binding sites contain
of the double helix at the binding site is necessary, thesethe base-paired 5-CpG-3 sequence, a known acri-
molecules may bind preferentially to dynamic base-dine intercalation site. However, RNA structure flank-
paired locations in an RNA target. In addition, the majoring this sequence causes binding affinities to vary over
and minor grooves of duplex RNA contain functional30-fold. The preferred site (KD  20 nM) contains a
groups that provide unique recognition surfaces. In-base-paired 5-CpG-3 step flanked on the 5 side by
deed, proteins that bind duplex RNA specifically (thea 4 nt internal loop and the 3 side by a bulged U.
dsRBM family of proteins) achieve their specificity bySeveral viral 5- and 3-UTR RNA sequences that likely
making multiple contacts to 2-hydroxyls and otherform binding sites for this PAC are identified.
groups present in the RNA minor groove [18]. Thus, we
have focused our efforts to develop RNA-selective small
Introduction molecules on compounds that have the potential to bind
via threading intercalation.
The development of low molecular weight compounds To this end, we have reported solid-phase synthesis
that bind RNA selectively is a research topic receiving protocols [19, 20] and screening strategies [21] for librar-
increasing attention [1–5]. One reason for this interest ies of substituted acridine derivatives. The acridine core
is the appreciation of RNA as a viable target for new of these compounds is modified with variable peptide
antibiotic drugs. There are several examples of clinically substituents emanating from the 4- and 9-positions (Fig-
useful compounds that bind to RNA of a pathogenic ure 1A), the substitution pattern of a known threading
organism [6]. For instance, the macrolide antibiotic intercalator [22]. We have termed our version of this
erythromycin A binds to the 23S ribosomal RNA of bac- structure the peptide-acridine conjugate, or PAC. The
teria near the peptidyl transferase loop, inhibiting the inspiration for the design of these molecules comes from
translocation step in protein synthesis [7]. Compounds nucleic acid binding natural products, such as nogala-
that bind other functionally important RNAs unique to mycin, which is a DNA sequence-selective threading
a pathogen could be developed into new therapeutics. intercalator (Figure 1B). Nogalamycin binds with its an-
Small molecules that bind RNA can also lead to the thraquinone intercalated and its nogalose and aminopy-
control of the activity of individual proteins. This has ranose substituents in the minor and major grooves of
been demonstrated through regulation of translation of duplex DNA, respectively [15, 23]. Its preferred binding
a particular protein by a small molecule binding to its sites are 5-PypG-3 steps within A•T-rich tracts [24].
mRNA and via the use of ligand-regulated RNA aptamers This has been rationalized by the observation in X-ray
that function as tunable inhibitors of a protein’s activity crystal structures of groove contacts between the car-
[8, 9]. Thus, in addition to their potential as new antibiot- bohydrate substituents and G•C base pairs, and the
ics, small molecules that bind RNA selectively are useful fact that A•T-rich DNA has a higher rate of base pair
tools for chemical biology. opening than G•C-rich or mixed sequence DNA [15, 24].
Unfortunately, our lack of understanding of the recog- Since threading intercalators may bind selectively to
nition of RNA by low molecular weight compounds limits duplex sites in RNA with unusual characteristics, such
our ability to design new, high-affinity ligands for differ- as non-Watson-Crick flanking structure or short base
ent RNA targets. Consequently, the systematic discov- pair lifetimes, we carried out in vitro evolution (SELEX)
ery of RNA-specific compounds is a field still in its in- experiments designed to identify RNA motifs predis-
fancy [3, 10, 11]. Interestingly, potential RNA targets posed to bind to a particular PAC. The highest-affinity
typically have regions of duplex secondary structure to RNA binding sites for the PAC studied consist of base-
paired 5-CpG-3 steps flanked on the 5 side by an
internal loop and on the 3 side by a U bulge. These*Correspondence: beal@chemistry.utah.edu
Chemistry & Biology
664
Figure 1. Chemical Structures of Small Mole-
cules that Bind Nucleic Acids by Threading
Intercalation
(A) Design of a peptide-acridine conjugate
(PAC).
(B) The natural product, nogalamycin. The in-
tercalating group in each structure is high-
lighted in orange.
results provide the basis for the design of PAC libraries heated to 65C, and these RNAs were cloned indepen-
dently (U aptamers). A total of 28 PAC binding aptamerto target this motif in naturally occurring, functionally
important RNA molecules. clones were sequenced (14 P and 14 U), and among
these, seven different sequences were represented (se-
quences a–g, Figure 3).Results
Secondary Structure PredictionSelection of PAC Binding Aptamers
and Structure ProbingTo isolate PAC binding RNAs, an affinity chromatogra-
The most stable secondary structures for the seven RNAphy resin was generated as previously described [25].
aptamer sequences were predicted using mfold [29, 30].Briefly, a PAC was synthesized by solid-phase methods
To test the validity of these structures, the RNAs werewith the sequence Abu-Ser-Val-Acr-Arg (Abu-SVAcrR),
cleaved with ribonucleases selective for certain second-where Abu is an aminobutyric acid linker and Acr is
ary structure elements. Results of these experimentsan acridine amino acid developed in our laboratory (1,
largely support the predicted structures for sequencesFigure 2) [20]. After purification by HPLC, this compound
a–c and g (see Supplemental Data at http://www.was immobilized via a reductive amination reaction in-
chembiol.com/cgi/content/full/10/7/663/DC1). For se-volving the N-terminal primary amine and a commer-
quence d, two structures of similar stability were pre-cially available aldehyde-functionalized agarose resin
dicted that could not be distinguished from the structure(2, Figure 2).
probing. In addition, the randomized region in se-We used a SELEX (systematic evolution of ligands by
quences e and f appeared to have evolved to be nearlyexponential enrichment) protocol to isolate RNA apta-
complementary to the fixed sequence present for PCRmers that bind the AbuSVAcrR resin from an initial pool
amplification and T7 transcription. For these reasons,of 75 nt RNAs containing a 30 nt sequence random
the three aptamers (d, e, and f) were not studied further.region (Figure 3) [9, 26–28]. In each round, the RNA
For sequences a, b, c, and g, the randomized regionpool was allowed to bind PAC resin 2 described above,
evolved to a self-complementary hairpin stem inter-followed by washing the unbound RNAs and eluting
rupted by a large internal loop (4 nt), with additionalthose bound with soluble PAC 1. To monitor the prog-
single nucleotide bulges present (Figure 4). Interestingly,ress through selections, the percentage of RNA pool
in each of these structures, the sequence 5-CGU-3 isthat bound to 2 was measured at each round. This num-
present in the stem with the 5-C•G base pair closingber rose from under 0.1% in the first round to approxi-
the large internal loop.mately 6% by the ninth round. The RNAs eluting from
the resin 2 with soluble PAC 1 in round ten were collected
and cloned (P aptamers). In addition, RNAs that re- Binding Site Identification with EDTA•Fe-PAC
We identified the binding sites for the PAC using affinitymained on the agarose resin after the PAC elution step
in round ten were removed using a 7 M urea solution cleaving with EDTA•Fe-modified ligand (3, Figure 2). The
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PAC binding sites on these RNAs have the common
structural element containing the 5-CGU-3 sequence
with the C and G base-paired, the U in a bulge or G•U
wobble pair, and the 5-C•G base pair adjacent to a loop
or bulged nucleotide. From the number of nucleotides
cleaved, it appears binding is less selective on the b
and c aptamers. In addition to the 5-CGU sequence,
the b aptamer has 5-CAU-3 present in the stem imme-
diately before the internal loop. In the c aptamer, the
5-CGU-3 sequence appears three times and 5-CAU
is also present in the evolved stem. These sequence
elements may constitute additional binding sites for the
PAC on these two RNAs.
Aptamers Bind the PAC with Different Affinities
The PAC binding affinities for the a, b, c, and g aptamers
were estimated using a quantitative ribonuclease foot-
printing assay. For each RNA, PAC 1 (Figure 2) inhibited
cleavage by ribonuclease V1 at nucleotides in the PAC
binding site. This effect was measured as a function of
PAC concentration and the data fit to generate a binding
isotherm for each aptamer (Figure 5). Interestingly, the
binding constants varied significantly for the different
aptamers with the g sequence binding with the highest
affinity (KD  21 nM) and the b sequence with the lowest
(KD  770 nM). The a and c sequence aptamers bound
the PAC with similar affinities (KD  145 nM and 90 nM,
respectively). The magnitude of the measured dissocia-
tion constant for sequence g was also determined using
a quantitative ribonuclease T1 footprinting assay. The
results of this experiment are in good agreement with
Figure 2. Chemical Structures of PAC Derivatives Used in This
the V1 footprinting on this RNA (KD  20 nM) (Figure 5).Study
The fact that the dissociation constants for the bindingThe PAC Abu-Ser-Val-Acr-Arg 1 was prepared by SPPS and used
of 1 to the different aptamers vary by over 30-fold under-to elute RNAs bound to the PAC resin 2 in the SELEX experiment.
scores the ability of this structure to discriminate amongThis PAC was also modified with EDTA•Fe and biotin to yield PACs
3 and 4, respectively. different RNA binding sites.
Minimal Binding Site from Sequence g Aptamerability of the tethered EDTA•Fe to generate hydroxyl
radicals and cleave RNA independent of sequence The PAC binding site on the aptamer with the highest
affinity (sequence g) was further characterized. The nu-allows for unambiguous determination of the PAC bind-
ing site [31, 32]. The cleavage reagent 3 was prepared cleotides cleaved by the EDTA•Fe-PAC 3 indicated the
PAC binding site resides in the center of the RNA in aby coupling EDTA monoanhydride [33] to the amino
terminus of the PAC SVAcrR while it was immobilized G•C-rich stem near a four nucleotide internal loop (Fig-
ure 4B). These results predict that much of the RNAon the solid phase synthesis support. Subsequent side
chain deprotection and cleavage from the support, sequence present in the 5 and 3 ends would be dis-
pensable for binding site formation. To test this idea, weHPLC purification, and addition of ferrous ion yields the
PAC 3. This compound efficiently cleaved nucleotides synthesized a 27 nt RNA lacking 25 nt from the 5-end
and 23 nt from the 3-end of the original g sequencein the evolved sequences, identifying the binding sites
for the PAC on the four aptamers studied (sequences aptamer. To determine if the binding site was main-
tained, the 27-mer was cleaved with compound 3. Im-a, b, c, and g) (Figure 4).
Figure 3. PAC Binding RNA Aptamers Identi-
fied in This Study
(A) Sequence of the initial RNA pool used for
SELEX experiments. RNAs are 75 nt long with
a 30 nt random region.
(B) Different RNA aptamers identified after 10
rounds of SELEX and the number of clones
containing that aptamer sequence.
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Analysis of PAC-RNA Binding by SPR
Surface plasmon resonance (SPR) studies were used to
explore the kinetics of PAC binding [34]. The PAC
SVAcrR was modified at its N terminus with a commer-
cially available -amino-biotinylated lysine residue to
yield biotin-KSVAcrR (4, Figure 2). This compound was
captured on a streptavidin-functionalized biosensor
chip for monitoring binding. The sensorgram generated
from the addition of various concentrations of the 27-
mer RNA is shown in Figure 6C. These binding data
were globally fit to a 1:1 interaction model to extract
association and dissociation rate constants using the
data analysis program CLAMP [35]. From this analysis,
ka  1.1  104 M1s1 and kd  1.7  102 s1, corre-
sponding to a KD 1.6M for this RNA. For comparison,
the full-length g sequence aptamer bound the PAC chip
with ka  5.3  103 M1s1, kd  6.9  103 s1, and
KD  1.3 M. Thus, the full-length aptamer and the
27-mer RNA bind with similar affinities and kinetics. It
is interesting to note that binding affinity to the full-
length aptamer is apparently lost by tethering the PAC
to the chip surface (KD  20 nM by footprinting, KD 
1.3 M by SPR).
Since intercalating ligands also have the potential to
bind DNA, we compared the binding of the PAC to the
27-mer RNA with its binding to a DNA duplex. This was
accomplished using a short DNA duplex corresponding
in sequence to that found in the base-paired region of
the 27-mer RNA (Figure 6D). Binding of the DNA 22-mer
to PAC 4 in SPR experiments required higher concentra-
tions and displayed considerably different binding kinet-
ics than observed with the RNA, indicating a different,
weaker binding mode for this nucleic acid. Indeed, the
KD obtained from the fit of the kinetic data is nearly two
orders of magnitude higher for the DNA (133 M) than
for the RNA 27-mer (1.5 M). This is primarily due to the
approximately 50-fold higher dissociation rate constant
for the PAC DNA interaction (kd  1 s1).
Discussion
Recently our laboratory and others have pursued the
goal of developing a systematic approach to the discov-
Figure 4. Characterization of Binding Sites on the RNA Aptamers ery of small molecules capable of controlling the func-
(A) Affinity cleavage of RNA aptamer sequence g using the EDTA•Fe- tion of RNA targets in vivo [8, 21, 36–51]. We have fo-
modified PAC 3. Shown is a storage phosphor autoradiogram of a cused our efforts on molecules with the potential to bind
10.5% denaturing polyacrylamide gel separating 5-end-labeled RNA in base-paired secondary structure via threading
RNA cleavage products. Major cleavage sites are near U31 and A46, intercalation. Binding of this type of compound can beand no other cleavage was observed. Structure probing: T1, RNase
specific due to stabilizing interactions between substitu-T1 (G lane); OH, alkaline hydrolysis; Alone, RNA in buffer only. Lanes
ents on the intercalator and functionality present in the1–7, increasing concentrations of PAC 3 (0, 0.01, 0.1, 1, 3, 6, 10 M)
with 0.01% H2O2 and 5 mM DTT; lane 8, control with 10 M SVAcrR grooves of the duplex or at bulged, mismatched, or
and 10 M free EDTA•Fe with 0.01% H2O2 and 5 mM DTT. looped nucleotides found adjacent to the intercalation
(B) Secondary structure of RNA sequence g as predicted by mfold site. In addition, this binding mode may be intrinsically
[29, 30], with blue arrows identifying cleaved nucleotides and red selective for base-paired regions in RNA that are highlyletters comprising the putative binding site.
dynamic due to the necessity for base-pair opening to(C) Secondary structures, cleaved nucleotides, and possible binding
allow for threading to occur. The compounds currentlysites for RNA sequences a, b, and c. See Experimental Procedures
for more details. under development by us for this purpose are peptide-
acridine conjugates (PACs), wherein the acridine hetero-
cycle is functionalized with peptide substituents at both
the 4- and 9-positions (Figure 1A). Since no high-resolu-portantly, the same nucleotides are cleaved on this RNA
as was observed with the full-length g sequence aptamer, tion structural data are available for complexes with
intercalators bound to RNA beyond dinucleotides, a de-indicating similar binding on both RNAs (Figure 6).
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Figure 5. RNase Footprinting Analysis
(A) Quantitative ribonuclease V1 footprinting with PAC 1 and RNA sequence g aptamer. Shown is a partial storage phosphor autoradiogram
of a 10.5% denaturing polyacrylamide gel separating 5-end-labeled RNA cleavage products. Structure probing: Alone, RNA in buffer only;
S1, S1 nuclease; A, RNase A; T1, RNase T1; OH, alkaline hydrolysis. Lanes 1–12, increasing concentrations of PAC 1 (0, 0.001, 0.003, 0.01,
0.03, 0.06, 0.1, 0.3, 1, 3, 6, 10 M) in the presence of RNase V1.
(B) Quantitative ribonuclease T1 footprinting with PAC 1 and RNA sequence g aptamer. Shown is a partial storage phosphor autoradiogram
of a 10.5% denaturing polyacrylamide gel separating 5-end-labeled RNA cleavage products. Structure probing: V1, RNase V1; A, RNase A;
S1, S1 nuclease; OH, alkaline hydrolysis; Alone, RNA in buffer only. Lanes 1–11, increasing concentrations of PAC 1 (0, 0.001, 0.01, 0.03, 0.1,
0.3, 1, 3, 10, 30, 100 M) in the presence of RNase T1.
(C) Plot of fraction bound versus concentration of PAC 1 as determined by RNase V1 footprinting.
(D) Table of KD values determined by RNase V1 and T1 footprinting.
sign/synthesis approach to selective, high-affinity li- the most selective cleavage is observed with a and g,
and least selective on c (Figure 4). The highest-affinitygands of this type is not currently feasible. One strategy
we have investigated is to generate libraries of these binding occurs with the g sequence where the 5-C•G
pair closes a four nucleotide asymmetric loop and themolecules and screen the libraries with various RNAs
from pathogenic organisms for ligands with high affinity U is bulged (Figures 4 and 5).
Our current model for the PAC-RNA complex formedand specificity [21]. To complement and guide these
experiments, we endeavored here to discover preferred at these binding sites involves intercalation of the acri-
dine at the 5-CpG/A-3 site. It is important to note thatRNA binding sites for a representative PAC using in vitro
evolution of the RNA (SELEX) [26]. The potential value the base-paired region (5-CpG/A-3)•(3-GpC/U-5) is
common to all the aptamer binding sites and the 5-in drug discovery efforts of using SELEX to identify RNA
motifs predisposed to bind certain organic compounds CpG-3 step is a well-characterized intercalation site for
acridines in duplex DNA [55]. Indeed, a recent crystalhas been discussed in the literature [27, 52–54]. The
PACs are well suited for study via this approach because structure of a 9-aminoacridine-4-carboxamide bound to
the DNA sequence (5-CGTACG-3)2 showed the acri-they are prepared by a simple, modular solid-phase syn-
thesis making the generation of derivatives easy and dine intercalated at both CpG steps with the 4-carboxa-
mide substituent making major groove contacts to therapid. Such derivatives include soluble PAC 1 and affin-
ity matrix 2, used during the selection, and compounds G [56, 57]. However, acridines do not bind exclusively
to CpG steps. Indeed, another structure of an acridine3 and 4, prepared for characterization of PAC-RNA com-
plexes. Future structure/function studies to determine derivative substituted at the 9-position with a tetraargi-
nine peptide has been reported with the acridine boundthe origin of binding affinity and selectivity will also be
facilitated by the simple, solid-phase PAC synthesis. at the ApA step in the DNA sequence 5-CGCGAATTC
GCG-3 [58]. Also, acridines have been shown to bindIt appears the sequence 5-C(G/A)U-3, wherein the
C and the purine are base-paired and the U is either to TAR RNA and U1A RNA in locations that do not con-
tain the CpG sequence [47, 59]. Thus, we could notbulged or in a G•U wobble, defines a binding site for
the PAC SVAcrR. In addition, there is an apparent re- have predicted a priori that we would observe such a
predominance of base-paired 5-CpG-3 steps in RNAsquirement for the 5-C•G pair to be adjacent to a loop
or bulge in the stem. This structure appears once in the selected against a peptide-acridine conjugate in such
an unbiased experiment. This study is the first of itsa and g aptamers, twice in b, and four times in the c
aptamer (Figure 4). The selectivity of cleavage by the kind to use RNA selection experiments to determine
preferred binding sites for a known intercalating ligand.EDTA•Fe PAC 3 is consistent with this definition since
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Figure 6. Characterization of the Binding to 27-mer RNA Derived from Sequence g Aptamer
(A) Storage phosphor autoradiogram of a 20% denaturing polyacrylamide gel separating 5-end-labeled RNA cleavage products. Structure
probing: T1, RNase T1 (G lane); OH, alkaline hydrolysis. Lane 1, control with 30 M SVAcrR and 30 M free EDTA•Fe with 0.01% H2O2 and
5 mM DTT; lane 2, RNA alone (in buffer only); lanes 3–11, increasing concentrations of PAC 3 (0.01, 0.1, 0.3, 0.6, 1, 3, 6, 10, and 30 M) with
0.01% H2O2 and 5 mM DTT. A21 is the most efficiently cleaved nucleotide (analogous to A46 in the full length RNA sequence g).
(B) Secondary structure of the 27-mer RNA as predicted by mfold [30, 31]. Black arrows identify cleaved nucleotides and outlined letters
indicate the putative binding site.
(C) SPR sensorgram for a 3-fold dilution series of 27-mer RNA binding to PAC 4 immobilized onto a streptavidin-coated biosensor chip starting
with 10 M.
(D) SPR sensorgram of a 3-fold dilution series of 22-mer DNA starting with 50 M. Overlayed on these sensorgrams is the curve fit as
determined by the data analysis program CLAMP [36].
The results shed new light on the value this sequence be facilitated in an RNA binding site with the CpG step
adjacent to nonhelical secondary structure. A similarin RNA as a PAC binding site, underscoring the impor-
tance of targeting naturally occurring RNAs that have explanation was used to rationalize why single base
bulges in an RNA duplex facilitates ethidium bromidethe CpG sequence with these compounds.
Importantly, the 5-CpG-3 sequence itself does not intercalation at a CpG step [60]. It is also possible that
direct contacts are made between the substituents ondefine the PAC binding site. In each of the PAC binding
aptamers, the base-paired 5-CpG-3 structure is sand- the acridine ring and nucleotides found in the loops and
bulges. Additional studies will be necessary to deter-wiched between non-Watson-Crick elements. Indeed, a
U always flanks this sequence on the 3 side, typically mine the relative importance of direct contacts between
the acridine substituents and looped or bulged nucleo-in a single base bulge or G•U pair. Furthermore, a C•G
pair closes a large internal loop (	4 nt) in each of the tides and the effects these structures have on RNA con-
formational flexibility. These efforts will benefit from theselected RNAs. The nature of the non-Watson-Crick
structure in the aptamers plays a significant role in de- observation that the binding site found in the 75 nt se-
quence g aptamer can be localized to a 27 nt stem-looptermining affinity as the dissociation constants for PAC
binding vary over 30-fold. The highest-affinity site con- structure (Figure 6).
The biotinylated PAC 4 bound weakly to a G•C-richtains a base-paired 5-CpG-3 step flanked on the 5
side by a 4 nt internal loop and the 3 side by a bulged DNA duplex, with the lower binding affinity a conse-
quence of significantly faster dissociation rate than ob-U. The presence of the loops and bulges likely affects
the base-pair dynamics at this site, rendering the inter- served with the 27-mer RNA (Figure 6). Acridine interca-
lators, such as proflavine, have been shown to bindcalation site accessible to a potential threading interca-
lator like SVAcrR. Furthermore, in acridine intercalation DNA in a two-step mechanism, rapidly forming an initial
“outside” or “groove bound” complex prior to formationcomplexes, significant unwinding of the helix is ob-
served at the intercalation site with overwinding at the of the more stable intercalation complex [61]. The out-
side complex formed with proflavine and calf thymusadjacent base pair. Distortion from the ground state
helical structure necessary to allow for intercalation may DNA dissociates approximately 40 times faster than
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C(A/G)U-3 is present with the C and the purine base-
paired, the U in a bulge or G•U wobble pair, and the
5-C•G pair adjacent to an internal loop. Future experi-
ments will determine if any of these sites are predis-
posed for PAC binding. If so, the RNA will become a
good candidate for screens against combinatorial librar-
ies of PAC derivatives to increase binding affinity and
selectivity.
Significance
Unbiased RNA selection experiments were used in this
study to determine preferred binding sites for a peptide-
acridine conjugate (PAC). In each of the RNA aptamers
studied, a PAC binding site contains a base-paired 5-
CpG-3 step, a known acridine intercalation site. These
results shed new light on the value of the 5-CpG-3
step in RNA as a PAC binding site, underscoring the
importance of targeting naturally occurring RNAs that
contain this structure with these compounds. However,
one of the most important observations in this study is
that the 5-CpG-3 step itself does not define a preferred
site for this PAC. Indeed, we have shown that a DNA
duplex containing two 5-CpG-3 steps binds with a KD
two orders of magnitude higher than does the high-Figure 7. Secondary Structures within Untranslated Regions of Viral
Genomes Containing a Putative PAC Binding Site affinity aptamer. The presence and nature of flanking
Structures originate from (A) IRES element in the 5-UTR of EMCV non-Watson-Crick structure play significant roles in de-
(strain B) [62]; (B) 5-UTR of CVB3 (strain Nancy) [63]; (C) 5-UTR of termining affinity. The preferred site (KD  20 nM) con-
CAV2 [64]; (D) 3-UTR of TEV [65]; and (E) 3-UTR of JE virus [66]. tains a 5-CpG-3 step flanked on the 5 side by a 4
Putative PAC binding sites have been highlighted in red.
nt internal loop and the 3 side by a bulged U. This
information is critical in identifying possible PAC binding
sites in naturally occurring RNAs and guiding future se-
does the intercalation complex [61]. Thus, the weak PAC lections from PAC libraries to optimize affinity and selec-
binding observed with the DNA duplex may be due to tivity. Indeed, using site selection criteria defined by
an outside, nonintercalative binding mode. Moreover, these experiments, potential PAC binding sites have
the bulky peptide substituents at the 4- and 9-positions been identified in the published secondary structures
on the acridine likely prevent insertion between the base of 5- and 3-UTRs from several viruses. In addition, the
pairs of the DNA duplex. Similar hindered binding has identification of a small RNA (27 nt) that binds well to
been observed previously with a derivative of proflavine the PAC sets the stage for high-resolution structural
with bulky substituents. 2,7-Di-t-butylproflavine is only studies that will aid in defining the basis for the binding
capable of forming the “outside” complex with DNA and selectivity observed.
does not intercalate [62].
The SELEX experiments described here have pro- Experimental Procedures
vided RNA structures that will continue to help us under-
Generalstand the RNA recognition properties of PACs. In addi-
Distilled, deionized water was used for all aqueous reactions andtion, the definition of preferred binding sites that comes
dilutions. All reagents were obtained from Sigma/Aldrich unless oth-from analysis of the SELEX results can be used to guide
erwise noted. Restriction enzymes and nucleic acid-modifying en-
the choice of naturally occurring target RNAs for screens zymes were purchased from New England Biolabs unless otherwise
against PAC libraries. We analyzed the published sec- noted. Oligonucleotides were prepared on a Perkin Elmer/ABI Model
392 DNA/RNA synthesizer with 
-cyanoethyl phophoramidites. 5-ondary structures for several viral 5- and 3-untrans-
Dimethoxytrityl (DMT)-protected 2-deoxyadenosine, 2-deoxygua-lated region (UTR) sequences to determine if structures
nosine, 2-deoxycytidine, and thymidine phosphoramidites werethat fit the criteria for a preferred binding site for the
purchased from Perkin Elmer/ABI. 2-O-Tertbutyldimethylsilyl (2-PAC were present. Viral UTRs contain key regulatory
O-TBDMS) protected adenosine, guanosine, cytidine, and uridine.
elements, often including an internal ribosomal entry Ribonucleoside phosphoramidites were purchased from Glen Re-
site (IRES) responsible for initiating translation of the search. [-32P]ATP and [-32P]ATP (6000 Ci/mmol) was obtained from
DuPont NEN. Storage phosphor autoradiography was carried outviral genome [63]. Thus, the binding of a small molecule
using imaging plates purchased from Kodak. A Molecular Dynamicsto structure found in the UTR may have a detrimental
STORM 840 and ImageQuant 5.2 software (Molecular Dynamics)effect on viral replication. In structures predicted for the
were used to obtain and analyze all data from phosphor imaging5-UTRs from encephalomyocarditis virus [64], coxsack-
plates, respectively.
ievirus B3 [65], and coxsackievirus A2 [66] and 3 UTRs
for tobacco etch virus [67] and Japanese encephalitis Synthesis of PAC Derivatives 1-4
[68] we found five potential PAC binding sites (Figures All PACs were synthesized using 9-fluoronylmethoxycarbonyl
(Fmoc)-protected amino acids (NovaBiochem) on Rink Amide MBHA7A–7E, respectively). In each case, the sequence 5-
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resin (NovaBiochem; 0.72 mmol/g loading) according to standard RNA Synthesis and End-Labeling
All 75 nt RNA aptamers were generated by run-off transcriptionSPPS protocols [69, 70]. Use of the 9-anilinoacridine amino acid
has been previously described [20]. The PAC sequence Abu-Ser- with T7 RNA polymerase. First, 100-mer dsDNA PCR products were
amplified from pUC-19 plasmids using 25-mer and 45-mer DNAVal-Acr-Arg (1) was cleaved from the solid-phase synthesis support
with Reagent B (TFA/TIS/H2O/phenol [90:5:2.5:2.5]). The resulting oligonucleotide primers. Sequences are as follows: 25-mer, 5-
CGGAAGCTTCTGCTACATGCAATGG-3, the HindIII restriction sitesolution was evaporated in vacuo and extracted between water and
diethyl ether. The acid aqueous layer was neutralized with triethyla- is italicized; 45-mer, 5-GCGAATTCTAATACGACTCACTCTCGGGA
GAGGATACTACACGTG-3, the EcoRI restriction site is italicizedmine and then concentrated by lyophilization. HPLC-purification
(to	95%) was performed on a reverse-phase C18 column (4.6 250 and the T7 promoter is underlined. The PCR product was extracted
with phenol/chloroform, ethanol precipitated, redissolved in 100 lmm, Vvdac) over 30 min with a flow rate of 1.5 ml/min. Compound 1
was analyzed by electrospray mass spectrometry (ESI-MS) on a reaction volumes consisting of transcription buffer [71], DTT (10
mM), NTPs (2 mM each), and RNasin (Amersham Pharmacia) andThermo Finnigan LC-Q Duo (San Jose, CA) instrument as previously
described [19]. Calculated mass for 1, 769.4; Found [MH], 770.5 incubated with T7 RNA polymerase at 40C overnight. The reaction
mixture was treated with RNase-free DNase I (Promega) for 3 hr atm/z. Stock solutions of all PACs were prepared to uniform UV ab-
sorbance (  442 nm) assuming a calculated extinction coefficient 37C. RNA aptamers were purified on a 10.5% denaturing polyacryl-
amide gel. Bands were visualized by UV shadowing and excisedof 6000 M1·cm1.
The covalent attachment of a soluble PAC to commercially avail- from the gel, followed by overnight elution via the crush and soak
method [71]. After filtration, the resulting solution was extracted withable aldehyde-functionalized agarose (PAC resin 2) has also been
described [25]. Briefly, the PAC was prepared for immobilization to phenol/chloroform, ethanol precipitated, and the RNA concentration
was determined by measuring the absorbance at 260 nm. For theAminoLinkPlus Coupling Gel (Pierce) by dilution of a stock solution
with pH 10 coupling buffer and addition of this mixture to the equili- preparation of 5-end-labeled RNA, 200 pmol of the transcript was
first treated with shrimp alkaline phosphatase (SAP, Amershambrated gel slurry. Reductive amination was achieved using sodium
cyanoborohydride. The remaining unreacted aldehyde sites on the Pharmacia) for 2 hr at 37C. SAP-treated RNA was gel purified and
isolated as described above. The dephosphorylated RNA was end-resin were blocked with a 1 M Tris buffer and subsequently reduced.
The substitution of the PAC on the agarose resin used for SELEX labeled using T4 polynucleotide kinase and [-32P]ATP for 1 hr at
37C. Labeled RNA aptamers were gel purified and isolated as de-experiments was 0.5 mol per ml (or 0.5 mM).
The EDTA•Fe-modified PAC 3 for affinity cleavage and the biotin- scribed above. 27-mer RNA was chemically synthesized and depro-
tected with NH3-saturated methanol for 24 hr at room temperature,ylated PAC 4 for SPR experiments were also prepared by SPPS.
The solid supported sequence Ser-Val-Acr-Arg was allowed to react followed by 0.1 M tetrabutylammonium fluoride (TBAF) in THF for
48 hr at room temperature. Deprotected RNA was purified on a 20%with EDTA monoanhydride [33] or activated Fmoc-Lys(Biotin)-OH
(Advanced ChemTech) in anhydrous DMF. The resulting PACs were denaturing gel and end-labeled as described above. The HPLC-
purified 22-mer DNA (U of Utah Health Sciences DNA/Peptide facil-deprotected, cleaved from the support, purified by HPLC, and char-
acterized by ESI-MS as described above. Calculated mass for 3 ity) was obtained 	95% pure.
(without iron), 958.4; Found [MH], 959.4 m/z. A 2-fold excess of
ammonium ferrous sulfate was added to an aqueous solution of the Secondary Structure Prediction and Structure Probing
EDTA-PAC to load it with iron. This compound was used for all Secondary structure prediction of all RNA sequences was per-
affinity cleavage experiments. Calculated mass for 4, 1038.5; Found formed using the web-based program mfold (version 3.1) developed
[MH], 1039.7 m/z. by Dr. Michael Zuker [29, 30]. Probing of the predicted structure
was accomplished by digesting the RNAs with 0.01 U RNase A
(Ambion), 1 U nuclease S1 (Amersham Pharmacia), 2 U RNase T1Random Library Preparation
A 75 nt DNA oligonucleotide (0.2 nmol) was used as the template (USB), and 0.1 U RNase V1 (Pierce). Reactions were carried out for 1
to 15 min at room temperature in 1SB under native (nondenaturing)for a three-cycle PCR reaction, which yielded a 100 bp dsDNA
product consisting of a T7 promoter and a 30-mer random region conditions and in the presence of 10 g/ml of yeast tRNAphe. In the
case of nuclease S1, reactions were supplied with 0.1 mM ZnCl2 forflanked by EcoRI and HindIII cloning sites. Transcription from this
DNA with T7 RNA polymerase generated a pool of 75 nt-long RNA optimal activity. Cleavage reactions were quenched with an equal
volume of formamide loading dye, heat denatured, and analyzed bymolecules. [-32P]ATP was used to body label the RNA pool for each
round of selection. (10.5% or 20%) denaturing polyacrylamide gel electrophoresis.
PAC EDTA•Fe Cleavage ExperimentsSELEX
In each round, 2 nmol of the RNA pool was denatured at 95C in PAC-RNA complexes were formed by incubating varying concentra-
tions of PAC 3 with 5 nM end-labeled RNA for 15 min in 1 SB0.5 ml of the selection buffer (1 SB: 50 mM Bis-Tris•HCl, 100 mM
NaCl, 10 mM MgCl2 [pH 7.0]) and allowed to slowly cool to room and 10g/ml of yeast tRNAphe. The resulting complexes were probed
by initiating hydroxyl radical formation with the addition of 0.01%temperature. The RNA pool was added to 100 l of Tris-capped
resin (preclear) and allowed to incubate for 30 min in order to exclude H2O2 and 5 mM DTT, followed by incubation at room temperature
for 30 min. Affinity cleaving reactions were quenched by the additionresin binding RNAs. The RNAs that did not bind the preclear resin
were incubated with 100 l of PAC resin 2 for 1 hr, followed by of 180 l of distilled H2O, followed by phenol/chloroform extraction
and ethanol precipitation. Cleaved RNA was resuspended in for-washing 10 times with 1 ml of wash buffer (1SB with additional 200
mM NaCl) to remove nonbinding RNAs. Bound RNAs were eluted by mamide loading dye, heat denatured, and analyzed by (10.5% or
20%) denaturing polyacrylamide gel electrophoresis.incubating the beads with 1 ml of 1 mM soluble PAC 1 for 30 min.
The eluted RNAs were rid of compound 1 using dialysis, then treated
with 5 units of RNase-free DNase I (Promega) for 3 hr at 37C. Access Quantitative Footprinting
RT-PCR kit (Promega) was used to amplify RNA winners from each Footprints for PAC 1 on RNA aptamers were obtained using RNase
round. The progress of selections was monitored by calculating the V1 and RNase T1 under native conditions. PAC-RNA complexes
percent of input RNA that was retained by PAC resin 2 after the were formed by incubating increasing concentrations of PAC 1 with
washing steps. This was accomplished by measuring the counts 1 nM end-labeled RNA for 15 min in 1 SB and 10 g/ml of yeast
per min of the two respective RNA pools (input and bound RNA). tRNAphe. Reactions were initiated by 5 min enzymatic digestions with
0.1 U RNase V1 or 2 U RNase T1, followed by quenching with
formamide loading dye. Cleaved RNA was heat denatured and ana-Cloning
The cDNA from the final round was digested with EcoRI and HindIII, lyzed by 10.5% denaturing polyacrylamide gel electrophoresis. The
cleavage efficiency at nucleotide(s) near the binding site was calcu-then cloned into pUC-19 plasmids and transformed into E. coli XL-1
Blue cells (Stratagene). Plasmids coding for individual RNA clones lated by normalizing for the differential loading for each concentra-
tion of PAC 1 tested. For the RNA sequence g aptamer, the footprintwere isolated, sequenced (U of Utah Health Sciences DNA sequenc-
ing facility), and used for subsequent production of RNA aptamers. of A46 cleaved by RNase V1 was monitored with respect to the V1-
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dependent constant band U54. For the RNase T1 footprint, the 10. Chow, C.S., and Bogdan, F.M. (1997). A structural basis for
RNA-ligand interactions. Chem. Rev. 97, 1489–1513.cleavage efficiency at G45 was monitored with respect to C50. Simi-
lar nucleotides were monitored for quantitative RNase V1 foot- 11. Michael, K., and Tor, Y. (1998). Designing novel RNA binders.
Chem. Eur. J. 4, 2091–2098.printing of sequence a, b, and c aptamers (see Supplemental Data
at http://www.chembiol.com/cgi/content/full/10/7/663/DC1). The 12. Wilson, W.D., and Jones, R.L. (1981). Intercalating drugs: DNA
binding and molecular pharmacology. Adv. Pharmacol. Chemo-cleavage data for each RNA was converted to binding data for PAC
1, assuming that the maximum cleavage efficiency corresponds to ther. 18, 177–222.
13. Wilson, W.D., Ratmeyer, L., Zhao, M., Strekowski, L., and Boy-0% occupancy by the PAC and the minimum cleavage efficiency
corresponds to 100% occupancy by the PAC. The fraction of RNA kin, D. (1993). The search for structure-specific nucleic acid-
interactive drugs: effects of compound structure on RNA versusaptamer bound by PAC 1 was plotted as a function of concentration,
and the data were fitted to the equation: fraction bound  [PAC 1]/ DNA interaction strength. Biochemistry 32, 4098–4104.
14. Nonin, S., Jiang, F., and Patel, D.J. (1997). Imino proton ex-[PAC 1]  KD. The results are reported as the average and standard
deviation for at least three different experiments. change and base-pair kinetics in the AMP-RNA aptamer com-
plex. J. Mol. Biol. 268, 359–374.
15. Liaw, Y.-C., Gao, Y.-G., Robinson, H., van der Marel, G.A., vanSurface Plasmon Resonance
Boom, J.H., and Wang, A.H.-J. (1989). Antitumor drug nogala-All binding studies were carried out on a Biacore S51 biosensor
mycin binds DNA in both grooves simultaneously: molecular(Biacore AB, Uppsala, Sweden). Approximately 4000 RU of strepta-
structure of nogalamycin-DNA complex. Biochemistry 28, 9913–vidin was immobilized onto a Pioneer Chip B1 using standard amine
9918.coupling chemistry. A biotinylated form of SVAcrR 4 was captured
16. Jourdan, M., Garcia, J., and Lhomme, J. (1999). Threading bis-onto the streptavidin surface at a density of 10 RU. RNA and DNA
intercalation of a macrocyclic bisacridine a abasic sites in DNA:analyte samples were injected over the SVAcrR and control surfaces
nuclear magnetic resonance and molecular modeling study.at a flow rate of 90 l/min. Bound complexes were dissociated with
Biochemistry 38, 14205–14213.a 10 s wash with 2.5 M guanidine HCl. Each analyte sample was
17. Guelev, V., Lee, J., Ward, J., Sorey, S., Hoffman, D.W., andinjected twice to demonstrate the reproducibility of the assay. All
Iverson, B.L. (2001). Peptide bis-intercalator binds DNA viadata were processed by subtracting out the response from the
threading mode with sequence specific contacts in the major
reference spot, along with subtracting out an average of 6 blank
groove. Chem. Biol. 8, 415–425.
injections. The responses were also normalized by the molecular
18. Ryter, J.M., and Schultz, S.C. (1998). Molecular basis of double-
mass of each analyte. The resulting data were globally fit using a
stranded RNA-protein interactions: structure of a dsRNA-bind-
1:1 interaction model in order to determine the reaction rate con-
ing domain complexed with dsRNA. EMBO J. 17, 7505–7513.
stants. The entire analysis was repeated to determine the reproduc-
19. Carlson, C.B., and Beal, P.A. (2000). Solid-phase synthesis of
ibility in reaction parameters. The ka, kd, and KD values were repro- acridine-peptide conjugates and their analysis by tandem mass
ducible to within 30%. spectrometry. Org. Lett. 2, 1465–1468.
20. Carlson, C.B., and Beal, P.A. (2000). Solid-phase synthesis of
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